🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

2,762 results for “CTI” Clear

  1. BIMERVAX LP.8.1 emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted)

    Hipra Human Health S.L.

    COVID-19

    approved small molecule active

    1 trial

  2. BIMERVAX LP.8.1 emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted), Spikevax bivalent Original/Omicron BA.1 25 micrograms/25 micrograms dispersion for injection COVID 19 mRNA Vaccine, Comirnaty 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine, Comirnaty JN.1 30 micrograms/dose dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine, Nuvaxovid dispersion for injection COVI

    The George Institute

    COVID-19 infection

    approved small molecule active

    1 trial

  3. BRONCHO-VAXOM® Kinder, 3,5 mg, Kapseln, Placebo to BRONCHO-VAXOM

    Lacuna Pharma Pty Ltd

    Respiratory Tract Infections with Wheezing Lower Respiratory Illness

    approved small molecule active

    1 trial

  4. BUDESONIDE

    The George Institute

    Chronic obstructive pulmonary disease (COPD)

    approved small molecule active

    1 trial

  5. BUP microdose induction

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorders

    approved small molecule terminated

    1 trial

  6. Benlysta 200 mg solution for injection in pre-filled pen.

    GlaxoSmithKline

    Systemic Lupus Erythematosus

    approved small molecule active

    1 trial

  7. Biktarvy 50 mg/200 mg/25 mg film-coated tablets

    Gilead Sciences Pty Limited

    HIV-1 infection

    approved small molecule active

    1 trial

  8. Bilaxten Flas 10 mg comprimidos bucodispersables

    A. Menarini Industrie Farmaceutiche Riunite s.r.l.

    Allergic rhinoconjunctivitis

    approved small molecule active

    1 trial

  9. Brodalumab 70 mg, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP, without the active substance., Kyntheum 210 mg solution for injection in pre-filled syringe

    LEO Pharma A/S

    Moderate-to-severe plaque psoriasis and a body weight ≥120 kg.

    approved small molecule active

    1 trial

  10. Brucea javanica oil emulsion injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    approved other active

    1 trial

  11. Bupivacaine Injection [Marcaine]

    The University of Hong Kong

    Acute Pain

    approved small molecule completed

    1 trial

  12. Bupivacaine Liposome Injection

    Jian Li

    Local Analgesia Via Infiltration

    approved small molecule active

    1 trial

  13. Buprenorphine Extended-Release Injection

    Indivior Pty Ltd

    Opioid Use Disorder

    approved small molecule completed

    1 trial

  14. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Attention Deficit Hyperactivity Disorder

    approved small molecule completed

    1 trial

  15. CAPVAXIVE solution for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (21-valent), Prevenar 20 suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)

    Disc Medicine

    Asplenia

    approved small molecule active

    1 trial

  16. CEFAZOLIN

    Pari Pharma GmbH

    Infection prophylaxis

    approved small molecule active

    1 trial

  17. CEFEPIME, TEICOPLANIN, METRONIDAZOLE, METRONIDAZOLE, MEROPENEM, TAZOBACTAM, VANCOMYCIN, LEVOFLOXACIN, CIPROFLOXACIN, CEFTAZIDIME, METRONIDAZOLE, CIPROFLOXACIN, LEVOFLOXACIN, AMIKACIN, CIPROFLOXACIN, PIPERACILLIN

    The George Institute

    Infectious diseases

    approved small molecule active

    1 trial

  18. COLECALCIFEROL , The Placebo product consists only of pure Ph. Eur. refined olive and it differs from Test product for the absence of active substance only: therefore, there are no reasons to suspect that the placebo product will undergo changes in its physical characteristics or degradation., Placebo

    Fondazione Telethon ETS

    obese elderly people with vitamin D deficiency

    approved small molecule active

    1 trial

  19. COVID-19 Vaccine (Vero cell), Inactivated

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  20. CYP2C19 genotyping

    Vera Therapeutics

    Myocardial Infarction

    approved gene therapy completed

    1 trial

  21. Carbetocin Short-infusion

    United Therapeutics Europe Ltd

    Complications; Cesarean Section

    approved small molecule completed

    1 trial

  22. Carvedilol NORMON 6.25 mg tablets EFG., Il n'a pas de substance active. Le produit est un comprimé pelliculé sécable blanc, de forme ovale, de longueur 8mm, avec une gravure F57 sur une face et une barre de sécabilité sur l’autre face. Excipients: Prosolv Easytab SP (Cellulose microcristalline, Silice colloïdale, Sodium starch glycolate, Sodium stéaryl fumarate). Solution de pelliculage: (Hypromellose, PEG 3350, Candurin silver sheen)

    Tour Hekla

    Asymptomatic Child-Pugh A5 to B8 cirrhosis

    approved small molecule active

    1 trial

  23. Ceftriaxon Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie, Ceftazidim Fresenius Kabi 500 mg poeder voor oplossing voor injectie, Amoxicilline/Clavulaanzuur Sandoz 2000 mg/200 mg i.v., poeder voor oplossing voor intraveneuze infusie, Cefuroxim Hikma 1500 mg poeder voor oplossing voor injectie of infusie, Meropenem CF 1000 mg, poeder voor oplossing voor injectie of infusie, Meropenem Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie, Piperacilline/Tazobactam Fresenius Kabi 2

    Disc Medicine

    Sepsis

    approved small molecule active

    1 trial

  24. Cellular Matrix / A-CP-HA Kit

    Regeneron Ireland Designated Activity Company (DAC)

    Genitourinary Syndrome of Menopause

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources